BioNumerik Pharmaceuticals Company
BioNumerik Pharmaceuticals discovers, develops and commercializes drugs for treating cancer.
Estimated Revenue:
$1M to $10M
Employee Number:
51-100
Industry:
PharmTech
Headquarters:
San Antonio, Texas, United States
Founded Date:
1992
Technology:
Neurological Disorders